The largest database of trusted experimental protocols

Inveon pet

Manufactured by Siemens
Sourced in United States

The Inveon PET is a preclinical PET imaging system designed for small animal research. It provides high-resolution imaging capabilities for studying biological processes in small animals such as mice and rats. The core function of the Inveon PET is to accurately capture and analyze PET data from small animal subjects.

Automatically generated - may contain errors

19 protocols using inveon pet

1

In Vivo PET Imaging of Mouse Biodistribution

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 17

The radiolabelling with Ga-68 was done as described before. The labelling reaction mixture was diluted in injection buffer (0.25 M Na-Acetate 0.05% Tween-20 pH 7) by a factor of 6 to obtain 150 pmoles in 100 μL injection buffer. The anaesthetized mouse (2% sevoflurane, Abbott) was injected with 100 μL of 68Ga-labelled 17-69-07-N144 and 17-69-07-N246 and placed in a small animal PET scanner (Inveon PET, Siemens). The imaging was performed 60 min post-injection and included a 15 min transmission scan before injection and a 60 min emission scan post-injection. Scans from PET imaging were reconstructed iteratively using the space alternating generalized expectation maximization method (SAGE, 16 subsets, 4 iterations) applying median root prior correction and were converted to standardized uptake value (SUV) images. Quantitation was accomplished using an ROI (region of interest) technique and expressed as SUVmean. Results from this study are shown in FIG. 12.

+ Open protocol
+ Expand
2

PET Imaging of Ga-68-labeled I-24

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 16

The radiolabelling with Ga-68 was done as described before. The labelling reaction mixture was diluted in injection buffer (0.25 M Na-Acetate 0.05% Tween-20 pH 7) by a factor of 6 to obtain 150 pmoles in 100 μL injection buffer. The anaesthetized mouse (2% sevoflurane, Abbott) was injected with 100 μL of 68Ga-labelled I-24 (19 MBq) and placed in a small animal PET scanner (Inveon PET, Siemens). The imaging was performed 60 min post-injection and included a 15 min transmission scan before injection and a 60 min emission scan post-injection. Scans from μPET imaging were reconstructed iteratively using the space alternating generalized expectation maximization method (SAGE, 16 subsets, 4 iterations) applying median root prior correction and were converted to standardized uptake value (SUV) images. Quantitation was accomplished using an ROI (region of interest) technique and expressed as SUVmean. Results from this study are shown in FIG. 11.

+ Open protocol
+ Expand
3

Small-Animal PET Imaging of 68Ga-NOTA-SAC

Check if the same lab product or an alternative is used in the 5 most similar protocols
We acquired small‐animal PET images by means of a micro PET scanner (Inveon PET, Siemens, Knoxville, TN, USA). Approximately 74 MBq (200 μCi/100 μL) of free 68Ga, 68Ga‐NOTA, and 68Ga‐NOTA‐SAC were intravenously administrated via the tail vein of each mouse (n = 4) under 1.5% isoflurane anesthesia. We did the CA IX blocking study by I. V injection of unradiolabelled‐pure saccharin (10 mg) first and then I. V injection of 68Ga‐NOTA‐SAC (74 MBq/100 μL) after about 1 h.
We acquired dynamic PET images at 90 min post injection (p.i) as whole‐body imaging. The acquired list mode PET images were reconstructed as three static frames (each 30 min) using a two‐dimensional order‐subset expectation maximization (OSEM)3D/SP‐MAP algorithm (OESM3D, 2 iterations; SP‐MAP, 18 iterations). The reconstructed dynamic PET images were then converted to standard uptake value (SUV), and the regions of interest (ROIs) were defined in the tumor region, liver region, and kidney region based on the whole‐body images. We quantitatively evaluated the distribution of radioactivity in each ROI by means of Inveon Research Workplace software (Siemens, Knoxville, TN, USA).
+ Open protocol
+ Expand
4

Fluorodeoxyglucose PET Imaging Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
μPET imaging was performed according to a previously published paper protocol (21 (link), 24 (link)). After an overnight fast, approximately 1 mCi of 18F-fluoro-2-deoxyglucose (FDG) was injected via tail vein injection. One hour after FDG injection, a 10 min μPET scan was conducted using Inveon PET (Siemens Medical Solutions, Knoxville, KY, USA). The maximum standardized uptake value (SUVmax), averaged uptake value (SUVmean), SUVmax normalized to rodents’ weight (maxSUV), and SUVmean normalized to rodents’ weight (meanSUV) were measured with the volume of interest (VOI) drawn on multiple tissues on PET images using the pMOD software (version 4.3, Switzerland). The SUVmax of the VOI was measured using the following formula: (decay-corrected activity [kBq] per tissue volume [mL])/(injected 18F-FDG activity [kBq] per body mass [g]). Immediately after μPET scan, the rats were euthanized in a CO2 chamber, and tissues were excised, weighted, and subjected to gamma counting (Wallac Wizard 3” 1480 Gamma Counter; PerkinElmer, Akron, OH, USA). FDG tissue biodistribution data were decay-corrected according to the time of FDG injection and normalized to both the tissue weight (g) and radioactivity level. In counting FDG activity in the various tissues, the counts per minute were normalized to the dose of radioactivity injected.
+ Open protocol
+ Expand
5

Micro-CT Analysis of Rodent Bone Microarchitecture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Micro-CT was performed in the left tibia of all rats. Imaging of the cortical and trabecular bones was performed using a micro-CT system (Inveon PET; Siemens Medical Solutions, Knoxville, TN, USA) with the following acquisition parameters: 80 kVp, 500 μA, 211-ms exposure time, 30.74 mm field of view and 60.04-μm pixel size. A global threshold value was set to binarize bone tissue from non-bone tissue. A global threshold was visually determined by two independent examiners (based on slice-wise 2D comparisons between the grey scale and segmented image of all samples). The region of interest was indicated in green color in the trabecular bone. The resulting images were evaluated using the Inveon acquisition workplace software (Siemens Medical Solutions). Parameters such as bone mineral density (BMD), bone surface area/bone volume (BSA/BV), bone volume/total volume (BV/TV), trabecular thickness (Tb.Th), trabecular spacing (Tb.Sp) and trabecular plate number (Tb.N) were calculated three-dimensionally from measurements of trabecular bone mass and its distribution. The results were reported according to the guidelines for assessment of bone microarchitecture of rodents using μCT [21 (link)].
+ Open protocol
+ Expand
6

Ga-68 PET Imaging of I-24 in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 16

The radiolabelling with Ga-68 was done as described before. The labelling reaction mixture was diluted in injection buffer (0.25 M Na-Acetate 0.05% Tween-20 pH 7) by a factor of 6 to obtain 150 pmoles in 100 μL injection buffer. The anaesthetized mouse (2% sevoflurane, Abbott) was injected with 100 μL of 68Ga-labelled I-24 (˜19 MBq) and placed in a small animal PET scanner (Inveon PET, Siemens). The imaging was performed 60 min post-injection and included a 15 min transmission scan before injection and a 60 min emission scan post-injection. Scans from μPET imaging were reconstructed iteratively using the space alternating generalized expectation maximization method (SAGE, 16 subsets, 4 iterations) applying median root prior correction and were converted to standardized uptake value (SUV) images. Quantitation was accomplished using an ROI (region of interest) technique and expressed as SUVmean. Results from this study are shown in FIG. 11.

+ Open protocol
+ Expand
7

PSMA Inhibitor PET Imaging in LNCaP Xenograft

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 7

Before injection into the mouse, the solution containing the purified 68Ga-CHX-DTPA-coupled PSMA inhibitor was sterile-filtered. 100 μl of this solution was taken up into a syringe and then injected into a BALB/c nude mouse LNCaP xenograft, intravenously into the tail vein. The PET scan was recorded for 140 min with a Siemens Inveon PET (FIG. 15)

+ Open protocol
+ Expand
8

Ga-68 Radiolabeling and PET Imaging of I-13 and I-15

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 20

The radiolabelling with Ga-68 was done as described before. The labelling reaction mixture was diluted in injection buffer (0.25 M Na-Acetate 0.05% Tween-20 pH 7) by a factor of 6 to obtain 150 pmoles in 100 μL injection buffer. The anaesthetized mouse (2% sevoflurane, Abbott) was injected with 100 μL of 68Ga-labelled I-13 and I-15 and placed in a small animal PET scanner (Inveon PET, Siemens). The imaging was performed 60 min post-injection and included a 15 min transmission scan before injection and a 60 min emission scan post-injection. Scans from μPET imaging were reconstructed iteratively using the space alternating generalized expectation maximization method (SAGE, 16 subsets, 4 iterations) applying median root prior correction and were converted to standardized uptake value (SUV) images. Quantitation was accomplished using an ROI (region of interest) technique and expressed as SUVmean.

The results of this study are shown in FIG. 18.

The high liver uptake of I-13 which has been shown already in the organ distribution (FIG. 15) could be confirmed in the PET imaging as well. I-15 presented with a clearly reduced liver uptake. The tumor signal was extremely high for both compounds.

+ Open protocol
+ Expand
9

FDG-PET Imaging of Cerebral Glucose Metabolism

Check if the same lab product or an alternative is used in the 5 most similar protocols
Siemens Inveon PET was used in this study [21 (link)]. Regional cerebral glucose metabolism was measured using 18F-fluorodeoxyglucose (FDG) PET. Before PET scanning, mice (n = 10 per group, female) fasted for at least 8 h, after which they were anesthetized with 2% isoflurane in 100% oxygen (Forane solution, Choongwae Pharma, Seoul, Korea). During PET scanning, the body temperature was maintained at 36 °C with heating pads. Then, 200 μCi of 18F-FDG was injected through a tail vein. After 30 min of uptake, 30-min emission PET data were acquired with an energy window of 350–650 keV. Emission list-mode data were sorted into three-dimensional (3D) sinograms and reconstructed using 3D reprojection algorithms. No filter was applied. The image matrix measured 256 × 256 × 159, the pixel size was 0.155 × 0.155 mm2, and the slice thickness was 0.796 mm.
+ Open protocol
+ Expand
10

Ga-68 Radiolabeling and PET Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 17

The radiolabelling with Ga-68 was done as described before. The labelling reaction mixture was diluted in injection buffer (0.25 M Na-Acetate 0.05% Tween-20 pH 7) by a factor of 6 to obtain 150 pmoles in 100 μL injection buffer. The anaesthetized mouse (2% sevoflurane, Abbott) was injected with 100 μL of 68Ga-labelled 17-69-07-N144 and 17-69-07-N246 and placed in a small animal PET scanner (Inveon PET, Siemens). The imaging was performed 60 min post-injection and included a 15 min transmission scan before injection and a 60 min emission scan post-injection. Scans from μPET imaging were reconstructed iteratively using the space alternating generalized expectation maximization method (SAGE, 16 subsets, 4 iterations) applying median root prior correction and were converted to standardized uptake value (SUV) images. Quantitation was accomplished using an ROI (region of interest) technique and expressed as SUVmean. Results from this study are shown in FIG. 12.

+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!